Inside the $63bn Deal Reshaping AI Finance
Published on 29 October 2026
Read article
Listen to article
5:51Hey! We are Nemo.
Nemo, short for Never Miss Out, is a mobile investment platform that delivers curated, data-driven investment ideas to your fingertips. It offers commission-free trading across stocks, ETFs, crypto, and CFDs, along with AI-powered tools, real-time market alerts, and themed stock collections called Nemes.
Download the App
Scan the QR code to download the Nemo app and start investing on Nemo today
It’s not often you see a giant of industry trip over its own feet so spectacularly. To me, Boeing’s current predicament with its 737 MAX production cap feels less like a temporary stumble and more like a seismic shift. The American Federal Aviation Administration has, quite rightly, put its foot down, and in doing so, has created a fascinating bottleneck in the global aircraft market. And whenever there’s a bottleneck, I find there’s usually an opportunity for someone else to find a clever way around it.
Let’s be clear, the world is crying out for new aeroplanes. Airlines are desperate to update their ageing fleets and meet the resurgent demand for travel. The problem is, one of the two biggest shops in town has a queueing system that’s been throttled by the regulators. Boeing simply cannot churn out its workhorse 737s at the rate the market demands. What happens when demand outstrips supply so dramatically? Well, customers start looking elsewhere. This isn't just a minor inconvenience, it's a golden invitation for Boeing's competitors to step up and win contracts that could define their order books for a decade or more.
Now, who is best placed to answer the call? I think the most interesting players aren't necessarily the obvious commercial rivals. Instead, my eyes are drawn to the grand, old titans of the defence world. Companies like Lockheed Martin, Northrop Grumman, and General Dynamics. These are not flighty start-ups, they are industrial behemoths with decades of experience building some of the most complex flying machines ever conceived. Lockheed’s F-35 programme, for instance, is a masterclass in high-tech, high-volume production. That sort of expertise is eminently transferable. They know how to navigate the labyrinth of government regulation because it’s their bread and butter.
What makes these firms particularly compelling, in my view, is their stability. They aren't solely reliant on the notoriously cyclical commercial aviation market. Their foundations are built on long-term, steady defence contracts. This means they aren’t betting the entire company on a single passenger jet programme. For an investor, that diversification is wonderfully reassuring. It provides exposure to the potential upside in aerospace without the white-knuckle ride of being tied exclusively to Boeing’s fortunes. This is precisely the thinking behind investment themes like the Aerospace Stocks Beyond Boeing Production Cap 2025, which focus on this broader, more resilient industrial base.
Of course, let’s not get carried away. There is no such thing as a risk-free investment, especially in a sector as complex as this. Defence budgets are subject to the whims of politicians, and a global economic downturn could clip the wings of the travel industry once more. These companies could face their own unique challenges, and we shouldn't assume Boeing will remain on the back foot forever. It is a formidable company that will, eventually, get its house in order. The real question for investors is whether its rivals can carve out a permanently larger slice of the market before that happens. To me, the current landscape suggests they have a fighting chance.
View the full Basket:Aerospace Stocks Beyond Boeing Production Cap 2025
View the full Basket:Aerospace Stocks Beyond Boeing Production Cap 2025
This article is marketing material and should not be construed as investment advice. No information set out in this article be considered, as advice, recommendation, offer, or a solicitation, to buy or sell any financial product, nor is it financial, investment, or trading advice. Any references to specific financial product or investment strategy are for illustrative / educational purposes only and subject to change without notice. It is the investor’s responsibility to evaluate any prospective investment, assess their own financial situation, and seek independent professional advice. Past performance is not indicative of future results. Please refer to our Risk Disclosure.
Published on 29 October 2026
Read article
Published on 28 October 2026
Read article
Published on 27 October 2026
Read article
Published on 26 October 2026
Read article
Published on 24 October 2026
Read article